title: [Curiosine administration for management of wound process after middle ear operations in otitis media].
abstract: Curiosine solution was used in surgical treatment of 80 patients with chronic otitis media purulenta early after the intervention. Otoscopic, cytological and bacteriological examinations have demonstrated that the drug creates physiological conditions for activation, migration and division of cells participating in tissue regeneration, it promotes bacterial decontamination of the wound. Curiosine can be used after radical operations on the middle ear.
authors.forename: D L
authors.initials: DL
authors.lastname: Perekhoda
authors.forename: F V
authors.initials: FV
authors.lastname: Semenov
authors.forename: A A
authors.initials: AA
authors.lastname: Evglevskiĭ
authors.forename: N P
authors.initials: NP
authors.lastname: Sokolova
mesh_terms: D000293:Adolescent; D000328:Adult; D000368:Aged; D002908:Chronic Disease; D003627:Data Interpretation, Statistical; D005260:Female; D006801:Humans; D006820:Hyaluronic Acid / Q000008:administration & dosage / Q000494:pharmacology / Q000627:therapeutic use*; D008297:Male; D008875:Middle Aged; D009942:Organometallic Compounds / Q000008:administration & dosage / Q000494:pharmacology / Q000627:therapeutic use*; D010035:Otitis Media, Suppurative / Q000601:surgery*; D012996:Solutions; D013530:Surgical Wound Infection / Q000517:prevention & control*; D013997:Time Factors; D014945:Wound Healing / Q000187:drug effects*
chemical_list: D009942:Organometallic Compounds; D012996:Solutions; C112514:zinc hyaluronate complex; D006820:Hyaluronic Acid